{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T14:26:05Z","timestamp":1744295165497},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>In this study the clinical features of patients with a serological overlap between scleroderma and primary biliary cirrhosis (PBC) were analysed. The entity was defined by the presence of both anti-centromere antibody (ACA) and anti-mitochrondrial antibodies to the M2 antigen, pyruvate dehydrogenase. In addition the sera were assayed for anti-mitochondrial antibodies to the M4 antigen measured by an ELISA to sulphite oxidase (SO). First, anti-M2 was detected, not only in 58 out of 60 patients with PBC but also in eight out 01 61 patients with ACA. These sera, together with sera from 53 normals and 99 from patients with various connective tissue diseases were then evaluated for anti-SO. which has been proposed by Klein and Berg to be a marker of progressive liver disease. Again, a high proportion (62%) of sera from patients with PBC were positive for anti-SO. and three of the eight patients who had ACA and anti-M2 also reacted with SO. We subsequently identified and included for study a further 10 patients positive for ACA and anti-M2, making a total of 18 patients with this profile. Features of limited cutaneous scleroderma were present in 94% and evidence of liver disease in 56%. Eight out of the 18 patients had anti-SO, and of these four had PBC. two had abnormal biochemical liver function tests but two had no evidence of liver disease. These data confirm that detection of anti-SO is limited to an anti-M2 sub-population, and may be a marker for liver involvement with prognostic significance in scleroderma patients with ACA.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1995.tb06646.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:34:12Z","timestamp":1280226852000},"page":"131-136","source":"Crossref","is-referenced-by-count":8,"title":["Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies"],"prefix":"10.1093","volume":"102","author":[{"given":"CC","family":"Bunn","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology. Royal Free Hospital and Medical School London. UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mcmorrow","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology. Royal Free Hospital and Medical School London. UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011518181448500_b1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM197309272891306","article-title":"The presentation and diagnosis of 100 patients with primary biliary cirrhosis","volume":"289","author":"Sherlock","year":"1973","journal-title":"N Engl J Med"},{"key":"2022011518181448500_b2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.41.6.612","article-title":"Anticentromere antibody in primary biliary cirrhosis","volume":"41","author":"Bernstein","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"2022011518181448500_b3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780260714","article-title":"Anticentromere antibodies in primary biliary cirrhosis.","volume":"26","author":"Makinen","year":"1983","journal-title":"Arthritis Rheum"},{"key":"2022011518181448500_b4","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.4049\/jimmunol.137.6.1855","article-title":"Identification and characterisation of mitochrondrial autoantigens in progressive systemic sclerosis identify with the 72000 dalton autoantigen in primary biliary cirrhosis","volume":"137","author":"Aldcruccio","year":"1986","journal-title":"J Immunol"},{"key":"2022011518181448500_b5","first-page":"75","article-title":"Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases","volume":"62","author":"Powell","year":"1987","journal-title":"Q J Med"},{"key":"2022011518181448500_b6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/art.1780310310","article-title":"Autoantibodies to mitochondria in systemic sclerosis","volume":"31","author":"Fregeau","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022011518181448500_b7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2249.1990.tb03325.x","article-title":"Autoantibodies to mitochondrial and centromere antigens in primary bliary cirrhosis and systemic sclerosis","volume":"81","author":"McHugh","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011518181448500_b8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1073\/pnas.77.3.1627","article-title":"Auto-antibody to centromere (kmetoehore) in scleroderma sera","volume":"77","author":"Moroi","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011518181448500_b9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.1780230602","article-title":"Diversity of antinuclear antibodies in progressive systemic sclerosis","volume":"23","author":"Tan","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022011518181448500_b10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0002-9343(80)90462-3","article-title":"The CREST syndrome: a distinct serological entity with anticerntromere antibodies","volume":"69","author":"Fritzler","year":"1980","journal-title":"Am J Med"},{"key":"2022011518181448500_b11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780270202","article-title":"Clinical and laboratory associations of anti-centromere antibody in patients with progressive systemic sclerosis","volume":"27","author":"Steen","year":"1984","journal-title":"Arthritis Rheum"},{"key":"2022011518181448500_b12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(65)91372-3","article-title":"Serological tests in diagnosis or PBC","volume":"i","author":"Walker","year":"1965","journal-title":"Lancet"},{"key":"2022011518181448500_b13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000171347","article-title":"Antimitochondrial antibodies in primry biliary cirrhosis and other disorders: definition and clinical relevance","volume":"10","author":"Berg","year":"1992","journal-title":"Dig Dis Sci"},{"key":"2022011518181448500_b14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0098-2997(85)90008-1","article-title":"Clinical and prognostic relevance of diffcrent antimitochondrial antibody profiles in primary biliary cirrhosis (PBC)","volume":"8","author":"Berg","year":"1985","journal-title":"Mol Aspects Med"},{"key":"2022011518181448500_b15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0168-8278(91)90903-O","article-title":"Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and progressive course of the disease: a retrospective analysis of 76 patienis over 6-18 years","volume":"12","author":"Klein","year":"1991","journal-title":"J Hepatol"},{"key":"2022011518181448500_b16","doi-asserted-by":"crossref","first-page":"8654","DOI":"10.1073\/pnas.85.22.8654","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011518181448500_b17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(88)91894-6","article-title":"Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens","volume":"i","author":"Yeaman","year":"1988","journal-title":"Lancet"},{"key":"2022011518181448500_b18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hep.1840100202","article-title":"Antimitochondrial autoantibodies in primary biliary cirrhosis recognise cross-reactive epitope(s) on protein X and dihydrolipoamide acetyltransferase of pyruvate dehydrogenase complex","volume":"10","author":"Surh","year":"1989","journal-title":"Hepatology"},{"key":"2022011518181448500_b19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N Engl J Med"},{"key":"2022011518181448500_b20","first-page":"68","article-title":"Characterisation of a new mitochondrial antigen-antibody system (M9\/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis","volume":"74","author":"Klein","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011518181448500_b21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2249.1990.tb05292.x","article-title":"Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase","volume":"81","author":"Klein","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011518181448500_b22","first-page":"445","article-title":"Anli-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase. an enzyme of the mitochondrial inter-membrane space.","volume":"84","author":"Klein","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011518181448500_b23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/hep.1840160505","article-title":"M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?","volume":"16","author":"Davis","year":"1992","journal-title":"Hepatology"},{"key":"2022011518181448500_b24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0168-8278(05)80253-3","article-title":"M4 and M9 autoantigens in primary biliary cirrhosis\u2014a negative study","volume":"18","author":"Palmer","year":"1993","journal-title":"J Hepatol"},{"key":"2022011518181448500_b25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepalology"},{"key":"2022011518181448500_b26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0168-8278(05)80056-X","article-title":"Anti-mitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of anti-mitochondrial antibody-subtypes after transplantation","volume":"20","author":"Klein","year":"1994","journal-title":"J Hepatol"},{"key":"2022011518181448500_b27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic non-supperative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1995.tb06646.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/102\/1\/131\/42203096\/j.1365-2249.1995.tb06646.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/102\/1\/131\/42203096\/j.1365-2249.1995.tb06646.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:40:13Z","timestamp":1685702413000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/102\/1\/131\/6484215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1995.tb06646.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1995,10]]},"published":{"date-parts":[[1995,10]]}}}